* BIOLASE Inc BIOL.OQ reported a quarterly adjusted loss of 2
cents per share for the quarter ended in September. The mean
expectation of four analysts for the quarter was for a loss of 3
cents per share.
* Revenue rose 45.8% to $9.53 million from a year ago; analysts
expected $8.78 million.
* BIOLASE Inc's reported EPS for the quarter was a loss of 2
cents.
* The mean earnings estimate of analysts had risen by
about 17.5% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* BIOLASE Inc shares had fallen by 4.4% this quarter and
gained 46.7% so far this year.
* The company reported a quarterly loss of $3.29 million.
* Wall Street's median 12-month price target for BIOLASE Inc is
$2.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated November 10 at 10:51 p.m.
All figures in US dollars unless otherwise stated